Daniel ShinYu Chen is Chief Medical Officer at IGM Biosciences, Inc. (IGMS). They have made 8 open-market trades across 1 company since 2020, most recently 2021-07-06.
CIK 0001787681
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IGMS | 116,518 | $148K |
Shares reported on the most recent Form 4, priced at the 2021-07-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IGMS | SELL | 2021-07-06 | 2021-07-06 | $82.75 | $156K | -0.4% | -5.7% | -24.5% |
| IGMS | SELL | 2021-06-02 | 2021-06-03 | $79.15 | $149K | -1.0% | -7.3% | -20.1% |
| IGMS | SELL · 10b5-1 | 2021-05-26 | 2021-05-28 | $70.00 | $31K | +24.9% | +13.1% | -4.9% |
| IGMS | SELL · 10b5-1 | 2021-05-05 | 2021-05-06 | $62.32 | $29K | +13.3% | +64.5% | +17.8% |
| IGMS | SELL | 2021-04-06 | 2021-04-07 | $82.00 | $100K | -29.1% | -19.1% | +0.5% |
| IGMS | SELL | 2021-03-02 | 2021-03-03 | $90.25 | $110K | +6.5% | +3.0% | -1.2% |
| IGMS | SELL | 2021-02-03 | 2021-02-04 | $96.00 | $118K | -5.7% | -31.0% | -41.8% |
| IGMS | SELL | 2021-01-05 | 2021-01-06 | $79.25 | $175K | +26.0% | +32.2% | +0.9% |
| IGMS | SELL | 2020-12-08 | 2020-12-09 | $91.00 | $111K | -20.2% | -18.4% | -22.3% |
| IGMS | SELL · 10b5-1 | 2020-12-02 | 2020-12-03 | $63.15 | $38K | +44.9% | +27.0% | +33.7% |
| IGMS | SELL · 10b5-1 | 2020-11-04 | 2020-11-04 | $50.00 | $30K | +8.0% | +25.1% | +92.8% |
| IGMS | SELL | 2020-10-02 | 2020-10-05 | $73.50 | $135K | +8.0% | -32.6% | +5.1% |
| IGMS | SELL · 10b5-1 | 2020-09-18 | 2020-09-18 | $77.91 | $47K | -9.1% | -12.8% | +5.4% |
| IGMS | SELL · 10b5-1 | 2020-09-08 | 2020-09-09 | $50.20 | $30K | +54.0% | +35.2% | +110.9% |
| IGMS | SELL · 10b5-1 | 2020-08-27 | 2020-08-28 | $45.13 | $27K | +34.2% | +68.1% | +50.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.